Dr. Lenz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
157 E Woodside Ave
Suite 809A
Patchogue, NY 11772Phone+1 631-475-1900Fax+1 631-475-1955
Education & Training
- University of Miami School of BusinessMBA, Health Sector Management and Policy, Valedictorian, 2010 - 2012
- University of MiamiM.B.A., Health Sector Management and Policy, 2010 - 2012
- University of MiamiCertificate, Clinical Scientists Training Program, 2003 - 2005
- University of Miami/Jackson Health SystemFellowship, Nephrology, 2001 - 2003
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2001
- Ludwig Maximilian University of Munich Faculty of MedicineClass of 1993, Dr.med.
Certifications & Licensure
- CA State Medical License 2024 - 2026
- FL State Medical License 2001 - 2026
- NY State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Teaching Award University of Miami, Division of Nephrology, 2004-2006, 2009, 2011, 2016, 2020
- Beta Gamma Sigma 2013
- Valedictorian Award University of Miami School of Business, 2012
- Join now to see all
Clinical Trials
- Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy Start of enrollment: 2005 Apr 01
Publications & Presentations
PubMed
- 50 citationsPatency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study.Arif Asif, Loay Salman, Roger G. Carrillo, Juan Garisto, Gustavo Lopera
Seminars in Dialysis. 2009-11-01 - 6 citationsAssessing Nephrology Fellows' Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad News.Lisa K. Prince, Anna Howle, Jeffrey Mikita, Brian C. Y’Barbo, Sharon Maynard
American Journal of Kidney Diseases. 2021-03-16 - 679 citationsMycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisGerald B. Appel, Gabriel Contreras, Mary Anne Dooley, Ellen M. Ginzler, David A. Isenberg
Journal of the American Society of Nephrology. 2009-05-01
Journal Articles
- Comparison of Mortality of ESRD Patients with Lupus by Initial Dialysis ModalityContreras G, Pagan J, Chokshi R, Virmani S, Diego JM, Byers P, Isakova T, Munoz Mendoza J, Nayer A, Contreras JR, Panama G, Lenz O, Carpintero M, Muchayi T, Roth D, Clin J Am Soc Nephrol. Clin J Am Soc Nephrol, 1/1/2014
- Phosphate Control in End Stage Renal Disease: Barriers and OpportunitiesWaheed AA, Pedraza F, Lenz O, Isakova T, Nephrol Dial Transplant, 1/1/2013
- Moving Points: Maintenance Therapy of Lupus Nephritis: Do we now have a plan?Lenz O, Waheed A, Baig A, Pop A, Contreras G, Clin J Am Soc Nephrol, 1/1/2013
- Join now to see all
Press Mentions
- Extraordinary Gift Names Division of Nephrology and HypertensionJanuary 4th, 2017
- Dr. Alessia Fornoni Named Chief of Division of Nephrology and HypertensionDecember 1st, 2016
Grant Support
- Clonal Selection In Diabetic NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
Professional Memberships
- Fellow
- Fellow
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: